Real-life data on pasireotide in monotherapy or combined in active Cushing’s disease

IntroductionIn the last few years, the use of medical treatment in Cushing’s disease (CD) has increased thanks to the availability of new molecules. Nevertheless, real-life data on combination treatments are still lacking.MethodsThis is a retrospective monocentric study evaluating the real-life effi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Alessandro Mondin, Filippo Ceccato, Carla Scaroni, Luca Denaro, Renzo Manara, Umberto Maria Robertazzo, Mattia Barbot
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2025-11-01
Col·lecció:Frontiers in Endocrinology
Matèries:
Cushing’s disease
somatostatin analogue
pasireotide
combination treatment
metyrapone
cabergoline
Accés en línia:https://www.frontiersin.org/articles/10.3389/fendo.2025.1695342/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars